Genocea Biosciences Inc (NASDAQ:GNCA)

8.75
Delayed Data
As of 11:48am ET
 +0.1201 / +1.39%
Today’s Change
6.15
Today|||52-Week Range
23.99
+25.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$154.2M

Company Description

Genocea Biosciences, Inc. operates as a clinical stage biotechnology company, which discovers and develops novel vaccines to address infectious diseases. The company uses its proprietary platform technology, antigen lead acquisition system to discover and develop novel vaccine candidates. Its products include GEN-001, GEN-002, GEN-003, GEN-004 and GEN-005. Genocea Biosciences was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.

Contact Information

Genocea Biosciences, Inc.
Cambridge Discovery Park
Cambridge Massachusetts 02140
P:(617) 876-8191
Investor Relations:
(617) 674-8261

Employees

Shareholders

Individual stakeholders45.67%
Mutual fund holders18.28%
Other institutional14.73%

Top Executives

William D. ClarkPresident, Chief Executive Officer & Director
Jonathan Michael PooleChief Financial & Accounting Officer
Jessica Baker FlechtnerSenior Vice President-Research
Seth V. HetheringtonChief Medical Officer
Robert E. FarrellVice President-Finance & Administration

To view my watchlist

Not a member yet?

Sign up now for a free account